Explore as a

Recipients

View recipients of the Hercus Medal.

Latest recipient

The 2018 Hercus Medal was awarded to Professor Brett Delahunt ONZM KStJ FRSNZ for his internationally recognised contributions as a pathologist, especially in relation to kidney and prostate cancer.

Previous recipients

2016

Professor Richard Beasley FRSNZ (for his significant contribution to the advancement of respiratory medicine and health science research in New Zealand)

2014

Parry Guilford FRSNZ (for his work that established the gene mutation that can lead to hereditary stomach cancer in families)

2012

John Fraser FRSNZ (for his pioneering studies on bacterial superantigens which have major implications for understanding and treating human infectious diseases)

2010

Alistair Gunn FRSNZ (for his exceptional contribution to perinatal physiology and clinical medicine both as a research scientist making breakthrough discoveries and as a research leader who is able to turn his research discoveries into clinically successful outcomes for babies

2008

Mark Richards FRSNZ (for his cardiovascular research for more than 30 years. Mark is one of the leading clinical scientists in the broad area of translational cardiovascular biology and medicine)

2006

Bruce Charles Baguley FRSNZ (for his significant contribution to the development of new cancer therapeutics)

2004

Joel Ivor Mann FRSNZ – for his extended series of related studies of nutrition in relation to diabetes and cardiovascular disease

2002

No award

2000

David Anthony Dougall Parry FRSNZ (for his extended series of related studies of the chemistry, physics, biochemistry, ultratructure, and biological function of fibrous proteins)

1999

David Christopher Graham Skegg FRSNZ (for consistently maintaining the highest standards in public health science and policy)

1998

Peter David Gluckman FRSNZ (for his pioneering work on the physiology of fetal growth and maturation, and the origins of brain injury at birth)

1997

Anthony Edmund Reeve FRSNZ (for research into applying DNA technology to develop an understanding of the genomic changes that lead to the onset of cancer)